日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth

用于治疗非移植合并症的免疫抑制药物与腹主动脉瘤生长无关

Thanigaimani, Shivshankar; Phie, James; Quigley, Frank; Bourke, Michael; Bourke, Bernie; Velu, Ramesh; Jenkins, Jason; Golledge, Jonathan

Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease

血清脂蛋白(a)与外周动脉疾病患者外周动脉手术需求及主要不良心血管事件发生率的相关性

Golledge, Jonathan; Rowbotham, Sophie; Velu, Ramesh; Quigley, Frank; Jenkins, Jason; Bourke, Michael; Bourke, Bernie; Thanigaimani, Shivshankar; Chan, Dick C; Watts, Gerald F

Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial.

随机安慰剂对照试验评估 24 周非诺贝特治疗对腹主动脉瘤循环标志物的影响:FAME-2 试验的结果

Pinchbeck Jenna L, Moxon Joseph V, Rowbotham Sophie E, Bourke Michael, Lazzaroni Sharon, Morton Susan K, Matthews Evan O, Hendy Kerolos, Jones Rhondda E, Bourke Bernie, Jaeggi Rene, Favot Danella, Quigley Frank, Jenkins Jason S, Reid Christopher M, Velu Ramesh, Golledge Jonathan

Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study

空腹血糖受损、糖尿病及其治疗与外周动脉疾病的发生和预后之间的关联:一项队列研究

Golledge, Jonathan; Quigley, Frank; Velu, Ramesh; Walker, Phillip J; Moxon, Joseph V